As a result of the recent restructuring at Pfizer, many talented Pfizer life sciences professionals are considering opportunities at other firms in Connecticut. Pfizer is working with Right Management to provide prospective employers more information about these individuals. For more, click here.
Following is a partial list of companies and organizations that are active in Connecticut bioscience and/or interested in recruiting people with bioscience backgrounds. The links below are direct to the job or career web pages of those organizations that have them, or to specific jobs that CURE knows about.
454 Life Sciences
The Jackson Laboratory
Protein Sciences Corporation
Purdue Pharma L.P.
Connecticut's bioscience sector continues to generate high-paying jobs and career opportunities. There are now almost 18,000 persons employed in the sector, in jobs requiring a variety of levels of preparation and skills. While the greatest demand is for persons with a scientific background, there are of course positions available for people with business and other supporting skills.
The effects of employment and spending by the State's bioscience industry are multiplied throughout the local economy. According to an independent analysis based on the CURE data, performed by Mark A. Thompson, Ph.D., Dean of the School of Business at Quinnipiac University, every bioscience job in Connecticut supported a total of 3.03 jobs in the State in 2005.
Because of high average salaries, the bioscience employment multiplier is one of the highest for Connecticut industries, according to Dr. Thompson. Other industries for which he has derived 2005 employment multipliers include: telecommunications, 2.80; insurance carriers, 2.36; residential construction, 2.18; ommercial construction, 1.76; and restaurants, 1.30.
According to Dr. Thompson's analysis, the total impact on the state's economy of employment in the bioscience industry was equivalent to almost 60,000 jobs, and the total impact of bioscience payroll and non-payroll spending in the state was over $10 billion.